Fractional CO2 Laser for Treatment of Vulvovaginal Atrophy: A Short Time Follow-up

Overview

Journal J Family Reprod Health

Date 2021 Feb 19

PMID 33603796

Citations 5

Authors

Zinat Ghanbari

Samira Sohbati

Tahereh Eftekhar

Leyla Sahebi

Soodabeh Darvish

Safa Alasiri

Marayam Deldar Pasikhani

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to evaluate the safety and efficacy of fractional CO2 laser for treatment of vulvovaginal atrophy. In this clinical trial study, we evaluated the laser effect on vulvovaginal atrophy in 47 women aged 43-80 years. Each woman was treated with fractional CO2 laser, SmartXide2V2LR, DEKA, Monalisa Touch, vaginal 360o probe and cosmetic probe. The severity of vulvovaginal atrophy symptoms was evaluated before first session of laser and every 4 weeks after laser treatment until 12 weeks. Adverse effects including pain and itching were assessed at all visits. The statistical analysis was performed using SPSS version 23. The response to laser therapy for vaginal dryness was significantly (p <0.001) improved. Also, the response to laser therapy for each symptom include dyspareunia, vaginal discharge, itching and urge urinary incontinence was statistically significant (p <0.001) based on visual analogue scale (VAS). It seems vaginal fractional CO2 laser can be applied as an effective and safe treatment method in genitourinary syndrome of menopause (GSM). It is necessary to conduct studies with long-term follow-up.

Citing Articles

Understanding the Benefits of CO Laser Treatment for Vulvovaginal Atrophy.

Jankovic S, Rovcanin M, Tomic A, Jurisic A, Milovanovic Z, Zamurovic M Medicina (Kaunas). 2024; 60(7).

PMID: 39064488 PMC: 11279000. DOI: 10.3390/medicina60071059.

Should I stay for local hormone therapy or should I go for radiofrequency to treat vulvovaginal atrophy? A patient preference trial.

DellUtri C, Manzoni E, Bonfanti I, Marrocco F, Barbara G, Pifarotti P Menopause. 2024; 31(9):801-808.

PMID: 38954491 PMC: 11469624. DOI: 10.1097/GME.0000000000002393.

Vaginal Laser Therapy for Stress Urinary Incontinence: A Systematic Review of Prospective Randomized Clinical Trials.

Ranjbar A, Mehrnoush V, Darsareh F, Kotb A, Zakaria A, Shekari M J Menopausal Med. 2023; 28(3):103-111.

PMID: 36647273 PMC: 9843031. DOI: 10.6118/jmm.22017.

New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review.

Benini V, Ruffolo A, Casiraghi A, Degliuomini R, Frigerio M, Braga A Medicina (Kaunas). 2022; 58(6).

PMID: 35744033 PMC: 9230595. DOI: 10.3390/medicina58060770.

The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state-of-the-art review.

Mortensen O, Christensen S, Lokkegaard E Acta Obstet Gynecol Scand. 2022; 101(6):657-692.

PMID: 35484706 PMC: 9564803. DOI: 10.1111/aogs.14353.

References

Nappi R, Kokot-Kierepa M . Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010; 67(3):233-8. DOI: 10.1016/j.maturitas.2010.08.001. View

Pieralli A, Fallani M, Becorpi A, Bianchi C, Corioni S, Longinotti M . Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Arch Gynecol Obstet. 2016; 294(4):841-6. DOI: 10.1007/s00404-016-4118-6. View

Weber M, Limpens J, Roovers J . Assessment of vaginal atrophy: a review. Int Urogynecol J. 2014; 26(1):15-28. DOI: 10.1007/s00192-014-2464-0. View

Ahluwalia J, Avram M, Ortiz A . Lasers and energy-based devices marketed for vaginal rejuvenation: A cross-sectional analysis of the MAUDE database. Lasers Surg Med. 2019; 51(8):671-677. DOI: 10.1002/lsm.23084. View

Behnia-Willison F, Sarraf S, Miller J, Mohamadi B, Care A, Lam A . Safety and long-term efficacy of fractional CO laser treatment in women suffering from genitourinary syndrome of menopause. Eur J Obstet Gynecol Reprod Biol. 2017; 213:39-44. DOI: 10.1016/j.ejogrb.2017.03.036. View

Sokol E, Karram M . An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause. 2016; 23(10):1102-7. DOI: 10.1097/GME.0000000000000700. View

Salvatore S, Leone Roberti Maggiore U, Athanasiou S, Origoni M, Candiani M, Calligaro A . Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause. 2015; 22(8):845-9. DOI: 10.1097/GME.0000000000000401. View

Hutchinson-Colas J, Segal S . Genitourinary syndrome of menopause and the use of laser therapy. Maturitas. 2015; 82(4):342-5. DOI: 10.1016/j.maturitas.2015.08.001. View

Perino A, Calligaro A, Forlani F, Tiberio C, Cucinella G, Svelato A . Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas. 2015; 80(3):296-301. DOI: 10.1016/j.maturitas.2014.12.006. View

10.

Portman D, Gass M . Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014; 21(10):1063-8. DOI: 10.1097/GME.0000000000000329. View

11.

Zerbinati N, Serati M, Origoni M, Candiani M, Iannitti T, Salvatore S . Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2014; 30(1):429-36. DOI: 10.1007/s10103-014-1677-2. View

12.

Salvatore S, Nappi R, Zerbinati N, Calligaro A, Ferrero S, Origoni M . A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014; 17(4):363-9. DOI: 10.3109/13697137.2014.899347. View

13.

Salvatore S, Nappi R, Parma M, Chionna R, Lagona F, Zerbinati N . Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy. Climacteric. 2014; 18(2):219-25. DOI: 10.3109/13697137.2014.975197. View

14.

Siliquini G, Tuninetti V, Bounous V, Bert F, Biglia N . Fractional CO laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women. Climacteric. 2017; 20(4):379-384. DOI: 10.1080/13697137.2017.1319815. View

15.

Arroyo C . Fractional CO laser treatment for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women. Int J Womens Health. 2017; 9:591-595. PMC: 5584900. DOI: 10.2147/IJWH.S136857. View

16.

Kim H, Kang S, Chung Y, Kim J, Kim M . The Recent Review of the Genitourinary Syndrome of Menopause. J Menopausal Med. 2015; 21(2):65-71. PMC: 4561742. DOI: 10.6118/jmm.2015.21.2.65. View

17.

Lang P, Dell J, Rosen L, Weiss P, Karram M . Fractional CO laser of the vagina for genitourinary syndrome of menopause: Is the out-of-pocket cost worth the outcome of treatment?. Lasers Surg Med. 2017; 49(10):882-885. DOI: 10.1002/lsm.22713. View